Thu, Jul 24, 2014, 12:13 AM EDT - U.S. Markets open in 9 hrs 17 mins


% | $
Click the to save as a favorite.

Dendreon Corp. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • Bio777a1 Bio777a1 May 9, 2007 3:10 PM Flag

    FDA Questions??? Please advise

    the letter from the FDA to DNDN stinks. From my experience the FDA should be following a special protocol to approve new meds for the terminally ill. The request from DNDN is for a med for the terminally ill prostrate cancer patient, not the mainstream patient. The basic sequence for approval is a double blind phase 3 clinical, results that indicate the med is safe, results that indicate limited side effects, and results that support improved quality of life and life extension. Where did DNDN miss? I believe it did not miss and that the FDA needs alittle more clarification. Mean while, the shorts have a picnic and DNDN is approved in a few weeks or months. Yes this stinks. JMO.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.17+0.07(+3.33%)Jul 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.